Reporting period: 2022-12-31 · Number of holdings: 1
KARLINSKI ANDREW C disclosed 1 holdings in its latest 13F filing for the period ending 2022-12-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
What is Karlinski Andrew C and what type of investor is it?
Karlinski Andrew C is an investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2022-12-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Karlinski Andrew C's largest equity positions?
Based on the latest 13F filing, Karlinski Andrew C's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Karlinski Andrew C make in its most recent portfolio filing?
No notable portfolio changes were recorded for Karlinski Andrew C in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Karlinski Andrew C focus on?
Sector breakdown data is not yet available for Karlinski Andrew C. Check back after the next 13F processing cycle.